Uttar Pradesh, India, Announces COVID-19-Free Status, Demonstrating IVERMECTIN’s Effectiveness as a “Deworming Drug”

COVID cases are declining in India, according to the Gateway Pundit, thanks to new policies that push Ivermectin and hydroxychloroquine to the country’s enormous population. COVID-19 has been lifted from 33 districts in Uttar Pradesh, India, the government announced on Friday. The recovery rate has risen to 98.7%, demonstrating IVERMECTIN’s effectiveness as part of the “Uttar Pradesh Covid Control Model.” Of course, the media will ignore the fact that Ivermectin is being used to treat COVID-19.

In 2021, this state is expected to have a population of 241 million people, making it India’s most populous. Even if this represents about two-thirds of the population of the United States in 2021,

Join The True Defender Telegram Chanel Here:

The Hindustan Times broke the news of this major development:

Overall, there are 199 active cases in the state, with a positive rate of less than 0.01 percent. Meanwhile, the recovery rate has increased to 98.7%. In the last 24 hours, Uttar Pradesh recorded only 11 new Covid-19 cases and zero deaths, according to the state’s health bulletin.

This was also covered by India Today on August 31:

The number of active cases in Uttar Pradesh has decreased to 269, with a ratio of active cases to total confirmed cases of 0%.

The active caseload has dropped by over 99 percent since April, when it peaked at 3,10,783.

For the past 50 days, the number of new Covid-19 cases in the state has stayed below 100.
In the last 24 hours, 21 of the 1,87,638 samples tested positive. Another 17 patients recovered from the infection at the same time period, bringing the total number of those who have recovered to 16,86,182 thus far. (Because these figures are in lakhs, the comma placement in the US is different.) 187,638) (1,87,638 lakh)

Uttar Pradesh leads India in the use of Ivermectin as early and preventatively as possible in all family connections. And despite having a low vaccination rate of 5.8% fully vaccinated compared to 54 percent fully vaccinated in the United States, this state has one of the five lowest COVID cases of all states in India.

As of September 14, the United States had 179,289,983 people fully vaccinated, while Uttar Pradesh had 15,236,150 people who had received their second dosage.

“Uttar Pradesh was the first state in the country to employ Ivermectin on a broad scale for both preventive and therapeutic purposes. Agra team led by Dr. Anshul Pareek provided Ivermectin to all RRT team members in the district on an experimental basis in May-June 2020. Despite being in constant touch with patients who had tested positive for the virus, none of them contracted Covid-19,” stated Uttar Pradesh State Surveillance Officer Vikssendu Agrawal.

According to the findings from Agra, the state government approved the use of Ivermectin as a preventive for all Covid patients’ contacts, and later cleared the administration of therapeutic doses for the patients.

“Despite being the state with the largest population base and a high population density, we have maintained a relatively low positivity rate and cases per million of population,” he said, claiming that the timely introduction of Ivermectin since the first wave has helped the state maintain a relatively low positivity rate despite its high population density.

He added that, in addition to active contact tracing and surveillance, the decreased positive and fatality rates in the state can be ascribed to the widespread use of Ivermectin, which was recently included in the National Protocol for Covid treatment and management. “Once the second wave has passed, we will undertake our investigation.”

The government of Uttar Pradesh sent a notice in August requesting Ivermectin (12 mg) tablets. According to the Dialogue:

“Doctors are suggesting to take ivermectin 12 mg to contain the impact of pandemic,” according to the government statement. This medication is quite good for preventing covid-19. As a result, we urge every citizen to obtain this tablet.”
The dosage is then explained: “For positive patients isolated at home (one pill per day for three days and for primary and secondary contacts,” according to the notification.

In a tweet from July, Australian MP Craig Kelly praised the Chief Minister of Uttar Pradesh for using Ivermectin as a prophylactic strategy.


Because Ivermectin is used early and preventatively in both Uttar Pradesh and Delhi, the number of COVID-19 cases has decreased dramatically. Kerala, a small state in southern India that is overly reliant on immunizations and under-reliant on Ivermectin, has seen a considerable spike in COVID-19 infections. Keep in mind that the population of Uttar Pradesh is eight times that of Kerala.

The Desert Review has more information on Kerala’s COVID- 19 cases:

“While Kerala included Ivermectin in their state’s guideline in April, they restricted it’s use to only in Class B – severe cases or those with associated disease, making its use much less than if mild cases were allowed. This meant it was reserved as a late treatment if used at all.

Finally, Kerala abandoned Ivermectin use altogether on August 5, 2021. 

Juan Chamie, the Cambridge-based data analyst who has provided graphical insight and published on COVID, provided his answer to why Kerala’s COVID cases have spun out of control.

“My main current explanation is the lack of early treatment. Kerala’s COVID protocol from April 2021 included Ivermectin, but not as an early treatment. As a result, only a small group qualified, those in Category B patients having high-risk factors. The new protocol from August 5 is even worse. They removed Ivermectin (completely).”

Despite a widespread attempt by the media and WHO to convince the world that India has dropped Ivermectin by citing the DGHS, the ICMR and AIIMS have not changed their position, and Ivermectin remains in the India National Protocol.”



Margaret Taylor

Experienced communications professional with 10 years of experience in international journalism.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Back to top button

This will close in 0 seconds

Adblock Detected

For continue reading on the site please disable the Ad-block